ClarVista Medical, Inc

 Company Summary:
  • ClarVista develops the HARMONI Modular IOL System, a novel intraocular lens (IOL) used to restore vision and improve patient outcomes after cataract surgery, the highest volume outpatient procedure.
Transaction Overview: Significance of the Transaction:
  • The Series B financing permit the Company to advance the clinical development of HARMONI Modular IOL capable of optimizing vision after cataract surgery.
  • Alcon, who also participated in the financing, acquired ClarVista Medical in 2017. Although terms were not publicly disclosed this outcome represented an ultimate exit and successful transaction for investors.
Healthios Role:
  • Healthios served as exclusive financial adviser to ClarVista Medical in its Series B financing.
  • This transaction highlights Healthios commitment to capital formation in emerging growth companies at pivotal points to increase near-term value and maximize shareholder interests.